Association between Metabolic Syndrome and Menstrual Irregularity in Middle-Aged Korean Women

다국어 초록 (Multilingual Abstract)

Background: Menstrual irregularity is a common major complaint in women of reproductive age. It is also a known marker for underlying insulin resistance. We investigated the association between menstrual irregularity and metabolic syndrome in the general population of middle-aged women in Korea. Methods: This cross-sectional study used data from the Korea National Health and Nutrition Examination Survey 2010–2012. A total of 2,742 subjects were included in the analysis. Participants were divided into two categories based on their menstrual cycle regularity and the relationship between metabolic syndrome and its variables was investigated by multiple logistic regression analysis. Results: Adjusted analyses revealed significantly higher odds ratios for metabolic syndrome, high waist circumference, high triglyceride levels, and low high density lipoprotein cholesterol levels with the presence of menstrual irregularity. Conclusion: Metabolic syndrome and its components (high waist circumference, high triglyceride levels, and low high density lipoprotein cholesterol levels) were significantly associated with menstrual irregularity in women of reproductive age.

참고문헌 (Reference)

1 Small CM, "Validity of self-reported menstrual cycle length" 17 : 163-170, 2007

2 전민영, "Validity and Reliability of Korean Version of International Physical Activity Questionnaire Short Form in the Elderly" 대한가정의학회 33 (33): 144-151, 2012

3 Robinson S, "The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries" 39 : 351-355, 1993

4 Park HR, "The metabolic syndrome in young Korean women with polycystic ovary syndrome" 77 (77): S243-S246, 2007

5 Graf MJ, "The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women" 33 : 119-131, 1990

6 Korea Centers for Disease Control and Prevention, "The Fifth Korea National Health and Nutrition Examination Survey (KNHANES V) 2010-2012" Korea Centers for Disease Control and Prevention 2012

7 Fraser IS, "The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding" 29 : 383-390, 2011

8 Reaven GM, "Role of insulin resistance in human disease (syndrome X):an expanded definition" 44 : 121-131, 1993

9 Christakou CD, "Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome" 4 : 583-594, 2008

10 Brown WJ, "Relationships between body mass index and well-being in young Australian women" 24 : 1360-1368, 2000

11 Dunaif A, "Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome" 38 : 1165-1174, 1989

12 Weerakiet S, "Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria" 23 : 153-160, 2007

13 Oh JY, "Prevalence and factor analysis of metabolic syndrome in an urban Korean population" 27 : 2027-2032, 2004

14 Apridonidze T, "Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome" 90 : 1929-1935, 2005

15 Setji TL, "Polycystic ovary syndrome: update on diagnosis and treatment" 127 : 912-919, 2014

16 Teede H, "Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan" 8 : 41-, 2010

17 American Academy of Pediatrics Committee on Adolescence, "Menstruation in girls and adolescents: using the menstrual cycle as a vital sign" 118 : 2245-2250, 2006

18 Castillo-Martinez L, "Menstrual cycle length disorders in 18- to 40-y-old obese women" 19 : 317-320, 2003

19 Bouzas IC, "Menstrual cycle alterations during adolescence: early expression of metabolic syndrome and polycystic ovary syndrome" 27 : 335-341, 2014

20 Glueck CJ, "Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome" 52 : 608-915, 2003

21 Joham AE, "Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity" 28 : 847-851, 2015

22 Weiss DJ, "Hyperinsulinemia is associated with menstrual irregularity and altered serum androgens in Pima Indian women" 43 : 803-807, 1994

23 Ecklund LC, "Endocrine and reproductive effects of polycystic ovarian syndrome" 42 : 55-65, 2015

24 Holte J, "Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome" 10 : 221-247, 1996

25 Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement" 112 : 2735-2752, 2005

26 Shen SY, "Clinical and biochemical characteristics of women with menstrual disturbance" 53 : 178-182, 2014

27 Dunaif A, "Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia" 65 : 499-507, 1987

28 Jukic AM, "Accuracy of reporting of menstrual cycle length" 167 : 25-33, 2008